Drugs / Autologous micro-fragmented adipose tissue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03167138 | Jul 2017 → Sep 2019 | rotator cuff syndrome, shoulder impingement syndrome, spinal cord injury, tendinitis | Kessler Foundation | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT03771989 Comparator | Jan 2019 → Feb 2022 | osteoarthritis, knee | Hvidovre University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous, micro-fragmented adipose tissue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03771989 ↗ |
| Route | Other | “injected into the injury site under ultrasound guidance” NCT03167138 ↗ |